Concepedia

The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity

Haley W. Sinn, Bennett D. Elzey, Robert J. Jensen, Xiuqin Zhao, Weicheng Zhao, Timothy L. Ratliff

Cancer Immunology Immunotherapy · 2007 · 30 citations · 38 references

DOIFull text

Open access

Concepts

References

38

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales et al. · The Journal of Urology · 1992 · 795 citations

, , +8

T-Cell Subsets Required for Intravesical BCG Immunotherapy for Bladder Cancer

Timothy L. Ratliff, Julie Ritchey, Jerry J.J. Yuan et al. · The Journal of Urology · 1993 · 292 citations

, , +16

Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder Cancer

William J. Catàlona, M’Liss A. Hudson, Daniel Gillen et al. · The Journal of Urology · 1987 · 289 citations

, , +6

Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor Activity

Timothy L. Ratliff, Daniel Gillen, William J. Catàlona · The Journal of Urology · 1987 · 233 citations

, , +15

COMPLICATIONS OF BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY

Donald L. Lamm · Urologic Clinics of North America · 1992 · 233 citations

, , +11